scispace - formally typeset
H

Hermann Josef Gröne

Researcher at German Cancer Research Center

Publications -  357
Citations -  25145

Hermann Josef Gröne is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Kidney & Chemokine. The author has an hindex of 82, co-authored 346 publications receiving 23147 citations.

Papers
More filters
Journal ArticleDOI

The hormetic functions of Wnt pathways in tubular injury

TL;DR: It is demonstrated that Dickkopf 3 (DKK3) is an agonist for canonical Wnt signaling in CKD and fosters chronic fibrosing inflammation of the tubulointerstitial compartment.
Journal ArticleDOI

Laser-controlled microdissection of tissues opens a window of new opportunities

TL;DR: In this review, different issues of the LCM technique and the RNA amplification procedure for microarray analysis are discussed and an exemplary summary of results obtained from gene profiling of epithelial and stromal cells from human prostate tumors is presented, demonstrating the power of LCM-based molecular analysis.
Journal ArticleDOI

Hypothalamic 3′,5′-Cyclic Adenosine Monophosphate Response Element-Binding Protein Loss Causes Anterior Pituitary Hypoplasia and Dwarfism in Mice

TL;DR: These findings show that CREB is required for the efficient production of GHRH in hypothalamus, in addition to its previously reported role in pituitary GH production and somatotroph expansion.
Journal ArticleDOI

Polymerase chain reaction detection of Puumala virus RNA in formaldehyde-fixed biopsy material

TL;DR: Investigation of kidney biopsies of patients with renal failure revealed a typical histopathological appearance for hantavirus infections in all seven suspected HFRS cases and one case of unknown cause, allowing insight into the molecular epidemiology of HFRS-causing agents.
Journal ArticleDOI

Anti-Inflammatory Effects of αv Integrin Antagonism in Acute Kidney Allograft Rejection

TL;DR: Data reveal an important role of this integrin subclass in leukocyte recruitment and development and maintenance of acute rejection; blockade of alpha(v) integrins may provide a new therapeutic strategy to attenuate acute allograft rejection.